Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Search help
1,969 results
  1. Gastrointestinal Complications (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65768
    ... Nausea and Vomiting a View in own window Adverse Event Grade Description Nausea b 1 Loss of appetite without alteration ...
  2. Nausea and Vomiting Related to Cancer Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK66056
    ... Events: N&V a View in own window Adverse Event Grade Description Nausea b 1 Loss of appetite without alteration ...
  3. Discussion - The Role of Immunotherapy in the Treatment of Asthma - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK513538
    ... of immunotherapy specifically on asthma. We tried to grade all adverse events using the WAO classification; however, many descriptions of the reactions (or the lack of description) ...
  4. Results - Outcomes of Sipuleucel-T Therapy - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK280062
    ... percent. In terms of severe infusion reactions rated grade 3 severity, these occurred in ... a brief text description in the FDA review describing analyses regarding associations ...
  5. NLM Digital Collections - Proton beam therapy : final evidence report 
    Publication: [Boston, MA] : Institute for Clinical and Economic Review, [2014]
    resource.nlm.nih.gov/101636381
    ... disorders, renal and urinary disorders) with guiding clinical descriptions for ... Grade 2 Moderate; minimal, local or noninvasive intervention indicated; ...
  6. NLM Digital Collections - Poly ADP-ribose polymerase (PARP) inhibitors for ovarian cancer : effectiveness and value : ... 
    Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, September 28, 2017
    resource.nlm.nih.gov/101723925
    ... in a small minority of patients (0-2%). Adverse event (AE) frequencies and ... drug-specific descriptions of safety data are presented in Appendix D. ...
  7. NLM Digital Collections - Modulator treatments for cystic fibrosis : effectiveness and value 
    Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, April 27, 2020
    resource.nlm.nih.gov/101769589
    ... D17. Meta-Analysis of Proportion of Patients with Grade 3 or 4 Adverse Events on Placebo Abbreviations: C.I.: ... Value Supplemental Information Description of evLYG Calculations The cost per evLYG considers ...
  8. Thyroid Cancer Treatment (Adult) (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65719
    ... 12.46–66.86; P < .001). Treatment-related adverse events (all grades) occurred in 97.3% of patients in the ... 12.46–66.86; P < .001). Treatment-related adverse events (all grades) occurred in 97.3% of patients in the ...
  9. Appendices - Cannabis-based medicinal products - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK552225
    ... experiencing adverse events, all-causality Withdrawals due to adverse events, all-causality Appendix G. GRADE tables THC:CBD spray vs placebo View in ...
  10. Results - Radiotherapy Treatments for Head and Neck Cancer Update - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK269023
    ... Group or the NCI Common Terminology Criteria for Adverse Events. Grades greater than 2 are those that have direct ... evidence on lesser NCI Common Terminology Criteria for Adverse Events or Radiation Therapy Oncology Group grades, as shown in Tables B-4 and B- ...
first · previous · 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · next · last